Status:
ACTIVE_NOT_RECRUITING
Latent Tuberculosis in Type 2 Diabetes
Lead Sponsor:
Taichung Veterans General Hospital
Conditions:
Latent Tuberculosis Infection
Eligibility:
All Genders
45+ years
Phase:
PHASE4
Brief Summary
The patients with poorly controlled DM underwent LTBI screening by using QuantiFERON (QFT). QFT-positivity predictors were evaluated. The patients with LTBI received tuberculosis preventive therapy, 9...
Detailed Description
Poor control of diabetes mellitus (DM) increases active tuberculosis (TB) risk. Understanding risk factors for latent TB infection (LTBI) in this population is crucial for policy making. Under a colla...
Eligibility Criteria
Inclusion
- aged ≥45 years
- poorly controlled DM (pDM), defined as HbA1c ≥9% within the preceding year
Exclusion
- active TB
- immunocompromise (use of immunosuppressors
- current pregnancy
Key Trial Info
Start Date :
April 18 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 18 2025
Estimated Enrollment :
552 Patients enrolled
Trial Details
Trial ID
NCT06874725
Start Date
April 18 2018
End Date
April 18 2025
Last Update
March 13 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Veterans General Hospital
Taichung, Taiwan, 407219